Herbs (Global Traditional) · European
Speedwell (Veronica officinalis) (Veronica officinalis)
Moderate Evidencebotanical
Hermetica Superfood Encyclopedia
Speedwell (Veronica officinalis) contains aucubin and saponins that may support digestive function by stimulating gastric acid production. The herb's bitter compounds traditionally promote digestion, while its anti-inflammatory properties show promise for joint and skin conditions in laboratory studies.
Speedwell (Veronica officinalis) is a perennial herbaceous plant native to Europe, whose above-ground parts (leaves and flowers) are harvested and dried to prepare medicinal extracts. The plant has been traditionally prepared as infusions or decoctions from dried herb material, though modern preparations may include standardized extracts containing specific bioactive compounds like aucubin and saponins.
The available research lacks specific human clinical trials, RCTs, or meta-analyses with PubMed PMIDs. A 2019 research paper by Salehi et al. in Molecules (vol. 24) identified phytochemical constituents including iridoid glycosides and phenolic compounds, but did not describe clinical efficacy trials. Both WebMD and RxList classify the evidence for speedwell's traditional uses as 'Insufficient Evidence' across all claimed conditions.
Herbal tea preparation: 1-2 teaspoons of dried herb per cup of hot water. No standardized extract dosages or clinical trial dosages are documented in the available sources. Consult a healthcare provider before starting any new supplement.
Speedwell (Veronica officinalis) is a low-calorie herb with limited macronutrient significance when consumed in typical medicinal quantities (teas, tinctures). Key bioactive compounds include: iridoid glycosides, primarily aucubin (estimated 0.3–1.2% dry weight), which exhibits anti-inflammatory and hepatoprotective properties with moderate oral bioavailability subject to gut microbiota metabolism; saponins (approximately 2–4% dry weight), contributing bitter and expectorant properties though with reduced bioavailability due to poor intestinal absorption; flavonoids including luteolin, apigenin, and veronicoside (collectively ~1–3% dry weight), with luteolin demonstrating moderate bioavailability (~20–30% absorption); caffeic acid derivatives and phenylpropanoid glycosides including verbascoside (acteoside), present at trace-to-low concentrations, with limited oral bioavailability (~5–15%). Tannins are present at approximately 2–5% dry weight, contributing astringent properties but reducing mineral bioavailability through chelation. Minerals detected include modest amounts of potassium, calcium, and magnesium, with no clinically significant concentrations documented. Vitamin C has been reported in fresh plant material at low levels (~10–20 mg/100g fresh weight). Dietary fiber content is present but not nutritionally significant in typical herbal doses. Essential oils are present in trace amounts (<0.1%), containing monoterpenes. Most bioactive compound concentrations are derived from phytochemical analyses of dried aerial parts; standardized concentration data across commercial preparations remains inconsistent.
Speedwell's bitter compounds stimulate taste receptors, triggering the vagus nerve to increase saliva and gastric acid secretion through the cephalic phase of digestion. Aucubin, an iridoid glycoside, inhibits pro-inflammatory cytokines like TNF-α and IL-1β in vitro. The saponin content may contribute to anti-inflammatory effects by modulating NF-κB signaling pathways.
No published randomized controlled trials exist for Veronica officinalis in humans. Traditional use data supports digestive applications, but lacks quantified clinical outcomes or standardized dosing protocols. In vitro studies demonstrate anti-inflammatory activity of isolated aucubin, but these laboratory findings require human validation. Current evidence remains insufficient to establish therapeutic efficacy or optimal dosing ranges.
Speedwell is generally considered safe when used traditionally as a tea or tincture, with no documented serious adverse effects. No known drug interactions have been reported, though theoretical concerns exist with anticoagulant medications due to potential effects on bleeding time. Pregnancy and breastfeeding safety data is unavailable, so use should be avoided during these periods. Individuals with gastroesophageal reflux should use caution due to gastric acid stimulation.
